HK43993A - 21-hydroxycorticosteroid esters,and compositions containing them - Google Patents

21-hydroxycorticosteroid esters,and compositions containing them

Info

Publication number
HK43993A
HK43993A HK439/93A HK43993A HK43993A HK 43993 A HK43993 A HK 43993A HK 439/93 A HK439/93 A HK 439/93A HK 43993 A HK43993 A HK 43993A HK 43993 A HK43993 A HK 43993A
Authority
HK
Hong Kong
Prior art keywords
hydroxycorticosteroid
esters
compositions containing
compositions
hydroxycorticosteroid esters
Prior art date
Application number
HK439/93A
Other languages
English (en)
Inventor
Bradley Dale Anderson
Robert Allen Conradi
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of HK43993A publication Critical patent/HK43993A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK439/93A 1983-01-21 1993-05-06 21-hydroxycorticosteroid esters,and compositions containing them HK43993A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/459,742 US4472392A (en) 1983-01-21 1983-01-21 Sulfonate containing ester prodrugs of corticosteroids

Publications (1)

Publication Number Publication Date
HK43993A true HK43993A (en) 1993-05-14

Family

ID=23825979

Family Applications (1)

Application Number Title Priority Date Filing Date
HK439/93A HK43993A (en) 1983-01-21 1993-05-06 21-hydroxycorticosteroid esters,and compositions containing them

Country Status (8)

Country Link
US (1) US4472392A (xx)
EP (1) EP0120557B1 (xx)
JP (1) JPS59137500A (xx)
CA (1) CA1199908A (xx)
DE (1) DE3478605D1 (xx)
HK (1) HK43993A (xx)
MX (1) MX9203197A (xx)
ZA (1) ZA838826B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1310009C (en) * 1984-03-28 1992-11-10 John Mark Braughler Ester prodrugs of steroids
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
US5446177A (en) * 1984-12-28 1995-08-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
JP2549724B2 (ja) * 1987-07-16 1996-10-30 ジ・アップジョン・カンパニー アルカンー１，ｎージカルボン酸モノー（２ースルファトエチル）アミド類のアミン塩類
BR9307746A (pt) * 1993-01-08 1995-11-14 Astra Ab Derivados de esteróides especificos para otratamento de cólon e ileo
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
WO2004017904A2 (en) * 2002-08-23 2004-03-04 The Mclean Hospital Corporation Corticosteroid conjugates and uses thereof
CA2537185A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
JP2009512677A (ja) * 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ホスホジエステラーゼタイプｉｖ阻害剤の組成物
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
CN103787927B (zh) * 2006-10-12 2017-03-01 Bhi有限合资公司 递送3‑氨基‑1‑丙磺酸的方法、化合物、组合物和载体
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
CA2680625C (en) 2007-03-14 2016-02-23 Ranbaxy Laboratories Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
BRPI0908229A8 (pt) * 2008-02-25 2017-10-10 Eyegate Pharma S A S Uso de um corticosteróide, derivado de corticosteróide, pró-fármaco ou sal deste, kit e dispositivo para dispensar iontoforeticamente um corticosteróide, derivado de corticosteróide, pró-fármaco ou sal deste no olho de um paciente para tratar um distúrbio ocular mediado por inflamação no referido paciente, e, formulação apropriada para dispensação iontoforética ocular de um corticosteróide, derivado de corticosteróide, pró-fármaco ou sal deste no olho de um paciente
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN116514829A (zh) * 2020-08-21 2023-08-01 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089881A (en) * 1957-10-29 1963-05-14 Schering Corp Sulfocarboxylic acid esters of hydroxylated steroids
US2986559A (en) * 1959-01-07 1961-05-30 Schering Corp Novel therapeutic salts and processes for their manufacture
US3171846A (en) * 1962-07-10 1965-03-02 Erba Carlo Spa Prednisolone-21-double esters
NL124139C (xx) * 1964-11-04
FR6590M (xx) * 1967-10-31 1968-12-30
US3609712A (en) * 1969-01-15 1971-09-28 Ibm Insulated gate field effect transistor memory array
US4221787A (en) * 1978-03-28 1980-09-09 Interx Research Corporation Esteramide prodrugs of anti-inflammatory corticosteroids
SU818489A3 (ru) * 1978-10-04 1981-03-30 Шеринг Аг (Фирма) Способ получени кортикоид -21- СульфОпРОпиОНАТОВ или иХ СОлЕй
DE2848423A1 (de) * 1978-11-08 1980-05-29 Merck Patent Gmbh Hydrocortisonester, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
MX9203197A (es) 1992-09-01
DE3478605D1 (en) 1989-07-13
US4472392A (en) 1984-09-18
JPH0226639B2 (xx) 1990-06-12
ZA838826B (en) 1984-07-25
EP0120557A2 (en) 1984-10-03
EP0120557B1 (en) 1989-06-07
JPS59137500A (ja) 1984-08-07
EP0120557A3 (en) 1985-02-06
CA1199908A (en) 1986-01-28

Similar Documents

Publication Publication Date Title
AR244895A1 (es) Una composicion sensible a la radiacion, un elemento sensible a la radiacion que la comprende y procedimiento para producir una imagen litografica en dicho elemento.
GB8406898D0 (en) Bis-maleimide-epoxy compositions
GB8417625D0 (en) Compounds and compositions
DE3478605D1 (en) 21-hydroxycorticosteroid esters, and compositions containing them
GB8417624D0 (en) Compounds and compositions
GB8417626D0 (en) Compounds and compositions
DE3479891D1 (en) 21-hydroxycorticosteroid esters, and compositions containing them
ZA84734B (en) Compositions
DE3460573D1 (en) Aluminium-filled compositions
DE3374569D1 (en) Siloxane-polyester compositions and use thereof
GB8334423D0 (en) Composition
GB8502534D0 (en) Compositions
DE3367105D1 (en) 21-hydroxycorticosteroid esters, and compositions containing them
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
KR920009397B1 (en) Bitumenous compositions
IL73471A (en) N,n-di-n-propyl-4-hydroxy-3-methanesulfonamido-phenethylamine and pharmaceutical compositions containing them
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
GB8321178D0 (en) Compositions
GB8334422D0 (en) Composition
GR82591B (en) Fumigating composition
PH19896A (en) 4-phenyl-tetrahydro-furano-pyridine and pharmaceutical compositions containing them
GB8420001D0 (en) Compositions
GB8412145D0 (en) Compounds and compositions
DE3463383D1 (en) 4-alkylindolonaphthyridines and pharmaceutical compositions containing them
GB8412144D0 (en) Compounds and compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)